Author: Amir Khakshaee (Amir Khakshaee)

Home / Amir Khakshaee
Post

Unintentional exposure of young children to adult acetaminophen tablets may pose serious health risks

Health Canada is advising Canadians to take precautions to prevent the unintentional exposure of young children to adult acetaminophen easy-to-swallow tablets following multiple incident reports to poison control centres. These tablets are red and sweet tasting, may seem like candy to young children, and can be packaged in bottles with a red, gear-shaped cap that...

Post

More COVID-19 Vaccine Info

 Dear Patients,  As you all know, the first vaccines are being given to higher risk people and health care workers. But we look forward to when we will have access to the vaccine. We do not yet know the place or the timing and we will communicate this when we do.  Some questions have arisen that...

Post

COVID-19 Vaccines

Dear community members and families, In the last few weeks, we have seen significant movement in our understanding of the COVID-19 vaccines. As of today, here is what we know: The vaccines are safe The vaccines approved for use in Canada work by sending a message to our body’s immune system to stimulate our natural immune response....

Post

Important Safety Information on the Authorization of Moderna COVID-19 Vaccine with English-only Vial and Carton Labels – Moderna Biopharma Canada Corporation

Moderna COVID-19 Vaccine was authorized for use in accordance with the Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19. As an extraordinary measure to provide earlier access to vaccine supplies in the context of the global pandemic, Moderna is providing, at this time, vaccine vials and cartons...

Post

3 Approved COVID-19 Vaccines Efficacy

Interim results of two large randomized, placebo-controlled trials (RCTs) demonstrate ~95% relative efficacy in preventing COVID-19 (Pfizer, Moderna). The AstraZeneca/Oxford vaccine has ~70% relative efficacy. Absolute benefits will vary with baseline risk and time but if annual risk of developing COVID-19 is 20%, then vaccine would decrease risk to 1% (6% with AstraZeneca/Oxford). These vaccines...

Post

Important Safety Information on ELMIRON (pentosan polysulfate sodium) and the Risk of Pigmentary Maculopathy – Janssen Inc.

Cases of pigmentary maculopathy have been reported with long-term use of ELMIRON. These changes may be irreversible, and retinal and vision changes may progress even after cessation of therapy. This medicine is usually used for urinary symptoms and pain associated with interstitial cystitis, a condition that presents with painful and frequent urination. HMC

Post

Pfizer-BioNTech COVID-19 vaccine: Health Canada recommendations for people with serious allergies

Two individuals in the U.K. reported severe allergic reactions to Pfizer BioNTech’s COVID-19 vaccine on December 8, 2020. As vaccine roll-out begins in Canada, Canadians may be wondering about the risks of allergic reactions and if they should receive this vaccine if they have allergies to foods or other medications. Health Canada has reviewed the...

Post

Contraception

Great tool from the Society of Obstetricians and Gynaecologists of Canada (SOGC) to choose your favourable and appropriate birth control method or contraception: https://itsaplan.ca Consult your physician for further advice and information. HMC

Post

Glucosamine and chondroitin for osteoarthritis pain

Glucosamine and chondroitin do not appear to be effective in higher-quality, larger and/or publicly funded studies. If studies at high risk of bias are included, at best ~10% more people will have meaningful reduction in pain with either treatment over 35-45% of people with placebo. There is reason to doubt the effectiveness of either treatments....

Post

Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) beyond 20 weeks of pregnancy and risk of kidney damage in unborn babies, leading to low amniotic fluid

Health Canada is investigating the use of NSAIDs at 20 weeks or later in pregnancy and the rare, but serious, risk of kidney problems in an unborn baby that can lead to low levels of amniotic fluid and possible complications, in response to a Drug Safety Communication recently released by the U.S. FDA on this...